Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Core EBITDA Growth

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 35.7080.69186.95-48.932.87

What is the latest Core EBITDA Growth ratio of NATCO PHARMA ?

The latest Core EBITDA Growth ratio of NATCO PHARMA is 35.70 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202535.70
Mar202480.69
Mar2023186.95
Mar2022-48.93
Mar20212.87

How is Core EBITDA Growth of NATCO PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 35.7
-55.76
Mar2024 80.69
-56.84
Mar2023 186.95
Positive
Mar2022 -48.93
Negative
Mar2021 2.87 -

Other Financial Ratios of NATCO PHARMA


Compare Core EBITDA Growth ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,428.8 Cr -2% -1.6% -1.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹470,270.0 Cr -1.5% 2.5% 14.5% Stock Analytics
DIVIS LABORATORIES ₹222,224.0 Cr 7.4% 22.2% 26.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,325.0 Cr 3.1% 4.3% 38.5% Stock Analytics
CIPLA ₹117,139.0 Cr -1.6% -1.4% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,876.6 Cr 1.5% -15.2% -9.1% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-2%

-1.6%

-1.4%

SENSEX

2.2%

0.9%

-3.7%


You may also like the below Video Courses